MEDVAMC initiates Aeterna Zentaris' AEZS-130 Phase 2A trial in cancer cachexia News-Medical-Net Thu, 08 Mar 2012 21:55 PM PST Aeterna Zentaris Inc. today announced that the Michael E. DeBakey Veterans Affairs Medical Center, in Houston, Texas, has initiated a Phase 2A trial assessing the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130 (macimorelin), in patients with cancer cachexia. | Golf: New cancer fight for Lyle sportal.com.au Thu, 08 Mar 2012 21:49 PM PST Australian professional golfer Jarrod Lyle has suffered a recurrence of leukaemia while preparing for the birth of his first child. | Natick rallying to help cancer warrior Natick Bulletin & Tab Thu, 08 Mar 2012 21:47 PM PST Through her foundation, longtime crossing guard Cheryl Chagnon has raised more than $280,000 for blood cancer research since 2002, donating all of it to Boston-area research centers searching for a cure. | Relay for Life campaign kicks off Grande Prairie Daily Herald-Tribune Thu, 08 Mar 2012 21:40 PM PST With roughly three months to go before the 10th annual Relay for Life kicks off, the Canadian Cancer society hopes to see participant numbers swell for this yearâs fundraiser.[...] | Jarrod Lyle has leukemia recurrence Yahoo! Sports Thu, 08 Mar 2012 21:34 PM PST Right when his life couldn't be any better, professional golfer Jarrod Lyle suffered a recurrence of leukemia upon returning home to Australia to prepare for the birth of his first child. Robert Allenby, who supports a cancer program that once had Lyle as a patient, said he received word Thursday morning that Lyle was going to start chemotherapy as soon as his wife gave birth. | Gazette.Net: New Micromet owner shakes up management Gazette.net Thu, 08 Mar 2012 21:32 PM PST Amgenâs $1.16 billion acquisition of Micromet was consummated this week, and with the deal came major changes in top management at the Rockville biotech thatâs developing cancer treatments. | Is Cancer Outwitting 'Personalized Medicine'? MedicineNet.com Thu, 08 Mar 2012 21:25 PM PST Title: Is Cancer Outwitting 'Personalized Medicine'? Category: Health News Created: 3/7/2012 6:06:00 PM Last Editorial Review: 3/8/2012 | NCCN issues new guidelines for AYA oncology patients News-Medical-Net Thu, 08 Mar 2012 21:11 PM PST The National Comprehensive Cancer Network announces that it has issued new NCCN Clinical Practice Guidelines in Oncology for Adolescent and Young Adult (AYA) Oncology. AYA patients are defined in the guidelines as individuals 15 to 39 years of age at initial cancer diagnosis. | | |
|